Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

Loxo Oncology, Inc. (LOXO)

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsSep-30-18Jun-30-18Mar-31-18Dec-31-17Sep-30-17Jun-30-17Mar-31-17Dec-31-16
   10-Q10-Q10-Q10-K10-Q10-Q10-Q10-K
Revenues  42.542.638.421.30.00.00.00.0
Cost of goods sold  0.00.00.00.00.00.00.00.0
Gross profit  42.542.638.421.30.00.00.00.0
            Gross margin  100.0%100.0%100.0%100.0%    
Selling, general and administrative   [+]15.915.712.212.79.76.54.84.0
Research and development  56.941.632.030.764.824.420.223.4
EBITDA   [+]-30.9-15.1-5.9-22.1-74.4-30.8-24.8-27.2
            EBITDA margin  -72.7%-35.5%-15.4%-103.9%    
Depreciation  -0.6-0.4-0.20.00.00.00.00.0
EBITA  -30.3-14.7-5.8-22.2-74.4-30.9-24.9-27.3
            EBITA margin  -71.4%-34.5%-15.0%-104.1%    
Amortization of intangibles     -0.10.00.00.10.1
EBIT   [+]-30.3-14.7-5.8-22.1-74.4-30.9-24.9-27.4
            EBIT margin  -71.4%-34.5%-15.0%-103.8%    
Interest income  3.33.02.21.51.10.50.40.2
Pre-tax income  -27.1-11.7-3.6-20.6-73.3-30.4-24.5-27.2
Income taxes  0.00.00.00.00.00.00.00.0
            Tax rate  0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%
Net income  -27.1-11.7-3.6-20.6-73.3-30.4-24.5-27.2
            Net margin  -63.7%-27.5%-9.3%-96.8%    
   
Basic EPS   [+]($0.89)($0.39)($0.12)($0.74)($2.45)($1.14)($0.96)($1.30)
Diluted EPS   [+]($0.89)($0.39)($0.12)($0.74)($2.45)($1.14)($0.96)($1.30)
   
Shares outstanding (basic)   [+]30.530.230.028.029.926.625.720.9
Shares outstanding (diluted)   [+]30.530.230.028.029.926.625.720.9
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy